Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Approval    entities : Astrazeneca plc    save search

WAINUA™ (eplontersen) granted regulatory approval in the U.S. for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis
Published: 2023-12-21 (Crawled : 00:00) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K twitter stocktwits trandingview |
Health Technology
| | O: 3.33% H: 0.0% C: -2.93%
IONS | $41.85 1.9% 1.86% 630K twitter stocktwits trandingview |
Health Technology
| | O: 1.43% H: 3.87% C: 2.77%
AZN | News | $70.85 1.03% 1.02% 5.6M twitter stocktwits trandingview |
Health Technology
| | O: 1.06% H: 0.18% C: -1.06%

granted approval treatment
Genprex Receives Safety Review Committee Approval to Advance to Phase 2 Expansion Portion of Acclaim-1 Clinical Trial of REQORSA® in Combination with Tagrisso® in Advanced Non-Small Cell Lung Cancer
Published: 2023-05-30 (Crawled : 13:00) - biospace.com/
AZNCF | News | $138.73 -4.19% 3.7K twitter stocktwits trandingview |
Health Technology
| | O: -0.34% H: 0.21% C: -2.03%
GNPX | $2.32 7.26% 6.77% 30K twitter stocktwits trandingview |
Health Technology
| | O: 1.12% H: 2.16% C: -10.76%
AZN | News | $70.85 1.03% 1.02% 5.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.44% H: 0.03% C: -1.94%

reqorsa lung approval review cancer cell expansion trial
Genprex Receives Safety Review Committee Approval to Proceed to Final Cohort in Acclaim-1 Phase 1 Dose Escalation Trial of REQORSA® in Combination with Tagrisso® in Advanced Non-Small Cell Lung Cancer
Published: 2022-12-14 (Crawled : 19:00) - biospace.com/
AZNCF | News | $138.73 -4.19% 3.7K twitter stocktwits trandingview |
Health Technology
| | O: -1.61% H: 1.82% C: 1.82%
GNPX | $2.32 7.26% 6.77% 30K twitter stocktwits trandingview |
Health Technology
| | O: 2.34% H: 5.98% C: -0.85%
AZN | News | $70.85 1.03% 1.02% 5.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.76% H: 1.04% C: 0.47%

reqorsa lung trial approval review cancer
Global Panic Disorders Market Insights | Size | Shares | Trends | Growth | Industry Analysis [2020-2030] Panic disorders, also known as anxiety disorder deals with recurrent and unexpected panic attacks. PET-CT Scanner Devices Market: Competitive Landscape Analysis With Forecast by 2031 Wilmington, Delaware: According to the report, the global PET-CT scanner devices market was valued over US$ 200 Mn in 2020 and is projected to expand at a CAGR of ~3% from 2021 to 2031. Portal Hypertension Market Insights | Current Trends | Growth Opportunity | Global Industry Analysis [2020-2030] At present, treatment options for portal hypertension is limited due to the dearth of approval of specialized drugs. Spatial Genomics & Transcriptomics Market to Experience Significant Growth by 2027 Wilmington, Delaware: The spatial genomics & transcriptomics market is prognosticated to bring profitable growth during the assessment period of 2019-2027. Teleradiology Services Market to Make Great Impact in Near Future by 2031 Wilmington, Delaware: According to the report, the global teleradiology services market was valued over US$ 6.4 Bn in 2020. Anti-depressants Drugs and Therapies Market to Witness a Pronounce Growth by 2025 Wilmington, Delaware: Anti-depressants medications lower the symptoms of depression, dysthymia, chronic depression, and anxiety disorders. B-Cell Non-Hodgkin’s Lymphoma (NHL) Market to Offer Ample Growth Opportunities by 2027 Wilmington, Delaware: Non-Hodgkin’s lymphoma is a group of heterogeneous proliferative malignancies. Heightening Healthcare Spending Opening Growth Avenues for Collateral Ligament Stabilizer System Market, Reaching US$ 3.5 Billion in 2032: Fact.MR Study Fact.MR – A Market Research and Competitive Intelligence Provider: The global collateral ligament stabilizer system market is expected to reach US$ 3.5 Billion by the end of the 2022-2032 forecast period, growing at a CAGR of 6.1%, concludes a recently published report by Fact.MR. Breast Cancer Liquid Biopsy Market Trends, Growth, Analysis and Future Scope, 2026 Wilmington, Delaware: A biopsy is a tissue or cell sample taken from any part of the patient’s body and examined in the lab for the detection of cancer. Cerebral Palsy Market Size, Shares, Trends and Growth | Global Industry Analysis [2020-2030] The global cerebral palsy market is picking up steam due to increasing awareness about the condition amongst parents. Continuous Glucose Monitoring Market: Competitive Research and Precise Outlook 2021 to 2028 Wilmington, Delaware: The global continuous glucose monitoring market depicts the presence of a large competitive vendor landscape, says Transparency Market Research on the basis of a newly research report. Crow’s Feet Market Key Trends and Opportunity Analysis up to 2026 Albany NY, United States: The demand within the global crow’s feet market has been escalating on account of vital advancements in the field of dermatology in recent times. HIV Associated Lipodystrophy Syndrome Market Insights | Global Industry Analysis [2020-2030] HIV-associated lipodystrophy is a syndrome that are found in human immune-deficiency virus -infected patients who are being administered with active antiretroviral medications for the treatment of HIV infection. Global Mail Service Pharmacy Market | Size | Shares | Trends | Growth | Forecast [2020-2030]
Published: 2022-06-03 (Crawled : 06:00) - biospace.com/
GLAXF | News | $20.305 -14.18% 630 twitter stocktwits trandingview |
Health Technology
| | O: -1.55% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K twitter stocktwits trandingview |
Health Technology
| | O: -0.94% H: 0.0% C: 0.0%
AZNCF | News | $138.73 -4.19% 3.7K twitter stocktwits trandingview |
Health Technology
| | O: -0.4% H: 4.05% C: -1.35%
PFE | News 4 | $26.32 0.23% 0.0% 24M twitter stocktwits trandingview |
Health Technology
| | O: 0.57% H: 0.0% C: 0.0%
GSK | News | $41.24 1.6% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.14% H: 0.0% C: 0.0%
LLY | News | $745.69 1.96% -0.16% 2M twitter stocktwits trandingview |
Health Technology
| | O: -2.25% H: 0.0% C: 0.0%
BMY | $48.99 -0.31% 0.0% 9.1M twitter stocktwits trandingview |
Health Technology
| | O: -1.4% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.09% H: 0.0% C: 0.0%
NBIX | News M | $140.11 4.83% 4.6% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 2.29% H: 0.0% C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.56% H: 0.82% C: -0.64%

lipodystrophy treatment research system active services report service growing hiv profitable hypertension genomics expected virus approval cancer growth group market breast cancer infections
Global Pharmaceutical API Manufacturing Market Report 2022-2030: Stringent Regulations for Approval of Pharmaceutical Drugs Restraining Growth
Published: 2022-04-12 (Crawled : 17:00) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K twitter stocktwits trandingview |
Health Technology
| | O: -0.86% H: 1.21% C: 1.21%
NVSEF | News | $95.11 6.88% 490 twitter stocktwits trandingview |
Health Technology
| | O: 0.16% H: 0.22% C: 0.22%
NVS | News | $97.28 2.27% 0.31% 3.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.48% H: 0.09% C: -0.68%
GSK | News | $41.24 1.6% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.36% H: 0.0% C: 0.0%
LLY | News | $745.69 1.96% -0.16% 2M twitter stocktwits trandingview |
Health Technology
| | O: -0.77% H: 0.99% C: 0.49%
ALB | News | $114.21 1.71% 0.0% 1.7M twitter stocktwits trandingview |
Process Industries
| | O: 1.31% H: 2.06% C: -1.76%
ABBV | News | $169.54 0.98% -0.91% 4.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.31% H: 0.74% C: -1.18%
SNY | News | $47.69 1.15% 1.13% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -3.25% H: 0.0% C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M twitter stocktwits trandingview |
Health Technology
| | O: -2.32% H: 0.43% C: -0.55%

report approval growth market drug
Lupus Research Alliance Applauds U.S. FDA Approval of AstraZeneca's anifrolumab-fnia (Saphnelo™) for Systemic Lupus Erythematosus (SLE)
Published: 2021-08-02 (Crawled : 12:00) - biospace.com/
AZN | News | $70.85 1.03% 1.02% 5.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.7% H: 0.86% C: 0.58%

fda fda approval research approval lupus
Alexion Announces FDA Approval of ULTOMIRIS® (ravulizumab-cwvz) for Children and Adolescents with Paroxysmal Nocturnal Hemoglobinuria (PNH)
Published: 2021-06-07 (Crawled : 19:00) - biospace.com/
AZN | News | $70.85 1.03% 1.02% 5.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.32% H: 0.6% C: -0.39%

fda fda approval children approval
Gainers vs Losers
78% 22%

Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M twitter stocktwits trandingview |

AGBA | $2.94 135.2% 57.48% 66M twitter stocktwits trandingview |
Finance

EDBL | News | $6.46 71.81% 41.8% 2M twitter stocktwits trandingview |

MTC | $2.25 44.23% 30.67% 6M twitter stocktwits trandingview |
Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M twitter stocktwits trandingview |
Finance

SHIM | $3.05 35.56% 26.23% 1.1M twitter stocktwits trandingview |

HKIT | $1.345 31.86% 24.16% 390K twitter stocktwits trandingview |
Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M twitter stocktwits trandingview |
Wholesale Trade

OST | $0.512 28.0% 21.88% 290K twitter stocktwits trandingview |

POET | $1.59 27.2% 21.38% 4.2M twitter stocktwits trandingview |
Manufacturing


Your saved searches
Save your searches and get alerts when important news are released.